Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
INVO Bioscience completes acquisition of Canadian-based entity » 08:07
09/09/21
09/09
08:07
09/09/21
08:07
INVO

INVO Bioscience

$3.68 /

-0.1 (-2.65%)

INVO Bioscience announced…

INVO Bioscience announced that it has completed the acquisition of a Canadian-based entity that was originally formed to offer INVOcell in Canada. The entity had previously completed a number of important procedures and documentation necessary to establish INVOcell within clinical operations in Canada. INVO Bioscience anticipates leveraging this entity to advance the distribution of INVOcell, and take advantage of the existing product registration which approved the device for sale based on 5-day incubation in the Canadian market. In addition, the Company is initiating the development of joint ventures to establish INVO Centers within the Canadian marketplace. Steve Shum, CEO of INVO Bioscience, commented, "We believe Canada offers an excellent opportunity to further expand our distribution efforts of INVOcell while also advancing our joint-venture based INVO Center model. With roughly 16% couples in Canada experiencing infertility, a number that has doubled since the 1980s, and with a popultion of 37.74 million, Canada represents a sizable market opportunity. Canada also faces similar issues that hamper other parts of the world, including a large underserved population, access/capacity constraints and affordability challenges. We appreciate the key individuals in Canada that originally created this entity to help promote and bring our INVOcell technology into the marketplace and look forward to bringing greater resources to advance this effort. We anticipate this acquisition will serve as a platform to help accelerate building INVOcell's presence in Canada."

ShowHide Related Items >><<
INVO INVO Bioscience
$3.68 /

-0.1 (-2.65%)

INVO INVO Bioscience
$3.68 /

-0.1 (-2.65%)

12/29/20 Roth Capital
Roth Capital starts INVO Bioscience with Buy, $5.75 price target
12/29/20 Roth Capital
INVO Bioscience initiated with a Buy at Roth Capital
12/15/20 Colliers
INVO Bioscience initiated with a Buy at Colliers
INVO INVO Bioscience
$3.68 /

-0.1 (-2.65%)

INVO INVO Bioscience
$3.68 /

-0.1 (-2.65%)

Hot Stocks
INVO Bioscience announces official opening of second INVO Center in US » 09:15
09/07/21
09/07
09:15
09/07/21
09:15
INVO

INVO Bioscience

$3.83 /

-0.1 (-2.54%)

INVO Bioscience announced…

INVO Bioscience announced as the official opening for the company's second INVO Center in the United States, based in Atlanta, Georgia. This new joint-venture, named "Bloom Fertility, an INVO Center," will focus on patients in need of advanced fertility care utilizing the efficient, effective, and affordable INVOcell solution. The Atlanta-based INVO Center becomes the second INVO Center to open and will begin seeing patients immediately and perform initial INVOcell treatment cycles in the month of October 2021. Earlier this month, INVO Bioscience announced the opening of the first INVO Center based in Birmingham, Alabama. Additional INVO Centers are scheduled to open, including one in Monterrey, Mexico for this year as well as the San Francisco Bay Area.

ShowHide Related Items >><<
INVO INVO Bioscience
$3.83 /

-0.1 (-2.54%)

INVO INVO Bioscience
$3.83 /

-0.1 (-2.54%)

12/29/20 Roth Capital
Roth Capital starts INVO Bioscience with Buy, $5.75 price target
12/29/20 Roth Capital
INVO Bioscience initiated with a Buy at Roth Capital
12/15/20 Colliers
INVO Bioscience initiated with a Buy at Colliers
INVO INVO Bioscience
$3.83 /

-0.1 (-2.54%)

INVO INVO Bioscience
$3.83 /

-0.1 (-2.54%)

INVO INVO Bioscience
$3.83 /

-0.1 (-2.54%)

Options
new option listings and three option delistings on August 25th » 08:30
08/25/21
08/25
08:30
08/25/21
08:30
BGSF

BG Staffing

$13.32 /

+0.255 (+1.95%)

, BSN

Broadstone Acquisition

$9.83 /

-0.01 (-0.10%)

, CXDO

Crexendo

$5.98 /

+0.18 (+3.10%)

, EDUT

EduTrek International Inc

$11.71 /

+0.28 (+2.45%)

, EPIX

Essa Pharma

$9.24 /

+0.615 (+7.13%)

, ERYP

Erytech Pharma

$5.89 /

+0.11 (+1.90%)

, FKWL

Franklin Wireless

$8.14 /

+0.05 (+0.62%)

, HBB

Hamilton Beach

$17.30 /

+0.16 (+0.93%)

, HFFG

HF Foods Group

$5.58 /

+0.11 (+2.01%)

, IMCC

IM Cannabis

$3.75 /

+0.21 (+5.93%)

, INVO

INVO Bioscience

$3.98 /

+0.065 (+1.66%)

, ISSC

Innovative Solutions

$6.80 /

-0.02 (-0.29%)

, ITOS

iTeos Therapeutics

$27.26 /

-0.79 (-2.82%)

, KXIN

Kaixin Auto

$3.27 /

-0.04 (-1.21%)

, LNSR

Lensar

$8.21 /

+0.25 (+3.14%)

, LYEL

Lyell Immunopharma

$15.47 /

-0.13 (-0.83%)

, NMTC

NeuroOne Medical Technologies

$4.50 /

+0.12 (+2.74%)

, RKLB

Rocket Lab USA

/

+

, SMRT

Stein Mart

/

+

, VEV

Vicinity Motor

$4.85 /

-0.1 (-2.02%)

, XGN

Exagen

$13.39 /

-0.235 (-1.73%)

, ZEST

Ecoark Holdings

$4.09 /

+0.03 (+0.74%)

, AJAX

Ajax I

$8.42 /

+0.365 (+4.53%)

, FWAA

Fifth Wall Acquisition Corp. I

$12.07 /

+0.41 (+3.52%)

, VACQ

Vector Acquisition

$11.50 /

+0.49 (+4.45%)

New option listings for…

New option listings for August 25th include BG Staffing (BGSF), Broadstone Acquisition Corp (Class A Stock) (BSN), Crexendo Inc (CXDO), Cazoo Group Ltd (Class A Stock) (CZOO), Global X Education ETF (EDUT), Alerian Energy Infrastructure (ENFR), Essa Pharma (EPIX), Erytech Pharma SA (ADR) (ERYP), Fidelity Total Bond ETF (FBND), First Trust Brazil AlphaDEX Fund (FBZ), Franklin Wireless Corporation (FKWL), Field Trip Health Ltd (FTRP), GCC (GCC), Hamilton Beach Brands Holding Company (Class A Stock) (HBB), HF Foods Group Inc (HFFG), IM Cannabis Corporation (IMCC), INVO BioScience Inc (INVO), Innovative Solutions (ISSC), iTeos Therapeutics Inc (ITOS), Kraneshares Cicc China 5g and Semiconductor Index ETF (KFVG), KraneShares Global Carbon ETF (KRBN), iShares Global Consumer (KXI), Kaixin Auto (KXIN), LENSAR Inc (LNSR), SPDR MSCI ACWI Low Carbon Target ETF (LOWC), Lyell Immunopharma Inc (LYEL), NeuroOne Medical Technologies Corporation (NMTC), Rocket Lab USA Inc (Class A Stock) (RKLB), ALPS Sector Dividend Dogs (SDOG), Sprott Junior Gold Miners ETF (SGDJ), Sprott Gold Miners (SGDM), SmartRent Inc (Class A Stock) (SMRT), Sonicshares Airlines Hotels Cruise Lines Etf (TRYP), Vicinity Motor Corporation (VEV), Global X Data Center REITs & Digital Infrastructure (VPN), Amplify International Online Retail ETF (XBUY), Exagen Inc (XGN), Ecoark Holdings Inc (ZEST), and Zega Buy and Hedge ETF (ZHDG). Option delistings effective August 25th include Ajax I (Class A Stock) (AJAX), Fifth Wall Acquisition Corporation I (Class A Stock) (FWAA), and Vector Acquisition Corporation (Class A Stock) (VACQ).

ShowHide Related Items >><<
ZEST Ecoark Holdings
$4.09 /

+0.03 (+0.74%)

XGN Exagen
$13.39 /

-0.235 (-1.73%)

VEV Vicinity Motor
$4.85 /

-0.1 (-2.02%)

VACQ Vector Acquisition
$11.50 /

+0.49 (+4.45%)

RKLB Rocket Lab USA
/

+

NMTC NeuroOne Medical Technologies
$4.50 /

+0.12 (+2.74%)

KXIN Kaixin Auto
$3.27 /

-0.04 (-1.21%)

ITOS iTeos Therapeutics
$27.26 /

-0.79 (-2.82%)

ISSC Innovative Solutions
$6.80 /

-0.02 (-0.29%)

INVO INVO Bioscience
$3.98 /

+0.065 (+1.66%)

IMCC IM Cannabis
$3.75 /

+0.21 (+5.93%)

HFFG HF Foods Group
$5.58 /

+0.11 (+2.01%)

HBB Hamilton Beach
$17.30 /

+0.16 (+0.93%)

FWAA Fifth Wall Acquisition Corp. I
$12.07 /

+0.41 (+3.52%)

FKWL Franklin Wireless
$8.14 /

+0.05 (+0.62%)

ERYP Erytech Pharma
$5.89 /

+0.11 (+1.90%)

EPIX Essa Pharma
$9.24 /

+0.615 (+7.13%)

BSN Broadstone Acquisition
$9.83 /

-0.01 (-0.10%)

AJAX Ajax I
$8.42 /

+0.365 (+4.53%)

BGSF BG Staffing
$13.32 /

+0.255 (+1.95%)

BSN Broadstone Acquisition
$9.83 /

-0.01 (-0.10%)

CXDO Crexendo
$5.98 /

+0.18 (+3.10%)

09/29/20 B. Riley
B. Riley FBR starts 'undervalued' Crexendo with Buy, $8 target
09/29/20 B. Riley
Crexendo initiated with a Buy at B. Riley FBR
EDUT EduTrek International Inc
$11.71 /

+0.28 (+2.45%)

EPIX Essa Pharma
$9.24 /

+0.615 (+7.13%)

08/16/21 Oppenheimer
Essa Pharma price target lowered to $22 from $36 at Oppenheimer
08/16/21 Piper Sandler
Essa Pharma readout delay raises some concerns, says Pper Sandler
04/23/21 Piper Sandler
Essa Pharma transferred with Overweight at Piper Sandler
03/04/21
Fly Intel: Top five analyst initiations
ERYP Erytech Pharma
$5.89 /

+0.11 (+1.90%)

FKWL Franklin Wireless
$8.14 /

+0.05 (+0.62%)

05/19/21 Lake Street
Franklin Wireless price target lowered to $16 from $28 at Lake Street
11/17/20 Lake Street
Franklin Wireless price target raised to $28 from $18 at Lake Street
09/21/20 Lake Street
Franklin Wireless price target raised to $18 from $16 at Lake Street
09/15/20 Lake Street
Franklin Wireless initiated with a Buy at Lake Street
HBB Hamilton Beach
$17.30 /

+0.16 (+0.93%)

07/27/21 Baird
Baird transfers coverage on Hamilton Beach, keeps at Neutral
HFFG HF Foods Group
$5.58 /

+0.11 (+2.01%)

IMCC IM Cannabis
$3.75 /

+0.21 (+5.93%)

08/18/21 Desjardins
IM Cannabis price target lowered to C$10.25 from C$10.50 at Desjardins
08/17/21 Alliance Global Partners
IM Cannabis price target lowered to $8 from $10 at Alliance Global Partners
07/29/21 Alliance Global Partners
Israel cannabis bill fails but market still robust, says Alliance Global Partner
07/15/21 Desjardins
Desjardins starts IM Cannabis with Buy on multi-country exposure
INVO INVO Bioscience
$3.98 /

+0.065 (+1.66%)

12/29/20 Roth Capital
Roth Capital starts INVO Bioscience with Buy, $5.75 price target
12/29/20 Roth Capital
INVO Bioscience initiated with a Buy at Roth Capital
12/15/20 Colliers
INVO Bioscience initiated with a Buy at Colliers
ISSC Innovative Solutions
$6.80 /

-0.02 (-0.29%)

ITOS iTeos Therapeutics
$27.26 /

-0.79 (-2.82%)

06/14/21 Piper Sandler
iTeos deal 'addresses a number of needs all at once, says Piper Sandler
05/19/21 SVB Leerink
iTeos Therapeutics price target lowered to $45 from $60 at SVB Leerink
05/14/21 Piper Sandler
iTeos Therapeutics recent pullback unwarranted, says Piper Sandler
05/05/21 H.C. Wainwright
iTeos Therapeutics initiated with a Buy at H.C. Wainwright
KXIN Kaixin Auto
$3.27 /

-0.04 (-1.21%)

LNSR Lensar
$8.21 /

+0.25 (+3.14%)

02/24/21 SVB Leerink
SVB Leerink bullish on Lensar, initiate with an Outperform
02/24/21 SVB Leerink
Lensar initiated with an Outperform at SVB Leerink
LYEL Lyell Immunopharma
$15.47 /

-0.13 (-0.83%)

07/12/21 JPMorgan
Lyell Immunopharma initiated with an Overweight at JPMorgan
07/12/21 Morgan Stanley
Lyell Immunopharma initiated with an Overweight at Morgan Stanley
07/12/21 BofA
Lyell Immunopharma initiated with a Buy at BofA
07/12/21 Goldman Sachs
Lyell Immunopharma initiated with a Buy at Goldman Sachs
NMTC NeuroOne Medical Technologies
$4.50 /

+0.12 (+2.74%)

RKLB Rocket Lab USA
/

+

SMRT Stein Mart
/

+

VEV Vicinity Motor
$4.85 /

-0.1 (-2.02%)

XGN Exagen
$13.39 /

-0.235 (-1.73%)

08/10/21 BTIG
Exagen price target lowered to $20 from $23 at BTIG
04/15/21
Fly Intel: Top five analyst initiations
04/15/21 Canaccord
Canaccord starts Exagen at Buy, sees 50% upside potential
04/15/21 Canaccord
Exagen initiated with a Buy at Canaccord
ZEST Ecoark Holdings
$4.09 /

+0.03 (+0.74%)

AJAX Ajax I
$8.42 /

+0.365 (+4.53%)

FWAA Fifth Wall Acquisition Corp. I
$12.07 /

+0.41 (+3.52%)

VACQ Vector Acquisition
$11.50 /

+0.49 (+4.45%)

ZEST Ecoark Holdings
$4.09 /

+0.03 (+0.74%)

XGN Exagen
$13.39 /

-0.235 (-1.73%)

ITOS iTeos Therapeutics
$27.26 /

-0.79 (-2.82%)

INVO INVO Bioscience
$3.98 /

+0.065 (+1.66%)

IMCC IM Cannabis
$3.75 /

+0.21 (+5.93%)

CXDO Crexendo
$5.98 /

+0.18 (+3.10%)

BGSF BG Staffing
$13.32 /

+0.255 (+1.95%)

  • 17
    Jun
  • 23
    Mar
  • 18
    Feb
  • 24
    Sep
VACQ Vector Acquisition
$11.50 /

+0.49 (+4.45%)

ITOS iTeos Therapeutics
$27.26 /

-0.79 (-2.82%)

FWAA Fifth Wall Acquisition Corp. I
$12.07 /

+0.41 (+3.52%)

XGN Exagen
$13.39 /

-0.235 (-1.73%)

VACQ Vector Acquisition
$11.50 /

+0.49 (+4.45%)

LYEL Lyell Immunopharma
$15.47 /

-0.13 (-0.83%)

KXIN Kaixin Auto
$3.27 /

-0.04 (-1.21%)

ITOS iTeos Therapeutics
$27.26 /

-0.79 (-2.82%)

INVO INVO Bioscience
$3.98 /

+0.065 (+1.66%)

IMCC IM Cannabis
$3.75 /

+0.21 (+5.93%)

FWAA Fifth Wall Acquisition Corp. I
$12.07 /

+0.41 (+3.52%)

ERYP Erytech Pharma
$5.89 /

+0.11 (+1.90%)

EPIX Essa Pharma
$9.24 /

+0.615 (+7.13%)

BSN Broadstone Acquisition
$9.83 /

-0.01 (-0.10%)

VACQ Vector Acquisition
$11.50 /

+0.49 (+4.45%)

KXIN Kaixin Auto
$3.27 /

-0.04 (-1.21%)

FWAA Fifth Wall Acquisition Corp. I
$12.07 /

+0.41 (+3.52%)

AJAX Ajax I
$8.42 /

+0.365 (+4.53%)

Over a month ago
Earnings
INVO Bioscience reports Q2 EPS (17c), consensus (20c) » 16:13
08/16/21
08/16
16:13
08/16/21
16:13
INVO

INVO Bioscience

$4.22 /

+0.06 (+1.44%)

Reports Q2 revenue…

Reports Q2 revenue $208.5M, consensus $410K. "Our team made excellent progress during Q2 toward our key objectives, headlined by last week's official opening of our first INVO Center practice in Birmingham, Alabama," commented CEO Steve Shum...The new Birmingham practice, our very first INVO Center, is a major milestone and one of the most significant in the Company's history to date. The center is already off to an encouraging start as we have surpassed our internal expectations for patient appointments and expected treatment cycles planned for the first month. The vision to drive accelerated adoption of the INVOcell solution while also increasing much needed capacity and patient access within the fertility industry is coming to reality with this first INVO Center, thanks to the expertise and commitment of our internal team and partners."

ShowHide Related Items >><<
INVO INVO Bioscience
$4.22 /

+0.06 (+1.44%)

INVO INVO Bioscience
$4.22 /

+0.06 (+1.44%)

12/29/20 Roth Capital
Roth Capital starts INVO Bioscience with Buy, $5.75 price target
12/29/20 Roth Capital
INVO Bioscience initiated with a Buy at Roth Capital
12/15/20 Colliers
INVO Bioscience initiated with a Buy at Colliers
INVO INVO Bioscience
$4.22 /

+0.06 (+1.44%)

INVO INVO Bioscience
$4.22 /

+0.06 (+1.44%)

Conference/Events
INVO Bioscience management to meet virtually with B. Riley » 04:55
07/27/21
07/27
04:55
07/27/21
04:55
INVO

INVO Bioscience

$4.14 /

-0.11 (-2.59%)

Virtual Meetings to be…

Virtual Meetings to be held on July 26-27 hosted by B. Riley.

ShowHide Related Items >><<
INVO INVO Bioscience
$4.14 /

-0.11 (-2.59%)

INVO INVO Bioscience
$4.14 /

-0.11 (-2.59%)

12/29/20 Roth Capital
Roth Capital starts INVO Bioscience with Buy, $5.75 price target
12/29/20 Roth Capital
INVO Bioscience initiated with a Buy at Roth Capital
12/15/20 Colliers
INVO Bioscience initiated with a Buy at Colliers
INVO INVO Bioscience
$4.14 /

-0.11 (-2.59%)

INVO INVO Bioscience
$4.14 /

-0.11 (-2.59%)

Conference/Events
INVO Bioscience management to meet virtually with B. Riley » 04:55
07/26/21
07/26
04:55
07/26/21
04:55
INVO

INVO Bioscience

$4.25 /

-0.04 (-0.93%)

Virtual Meetings to be…

Virtual Meetings to be held on July 26-27 hosted by B. Riley.

ShowHide Related Items >><<
INVO INVO Bioscience
$4.25 /

-0.04 (-0.93%)

INVO INVO Bioscience
$4.25 /

-0.04 (-0.93%)

12/29/20 Roth Capital
Roth Capital starts INVO Bioscience with Buy, $5.75 price target
12/29/20 Roth Capital
INVO Bioscience initiated with a Buy at Roth Capital
12/15/20 Colliers
INVO Bioscience initiated with a Buy at Colliers
INVO INVO Bioscience
$4.25 /

-0.04 (-0.93%)

INVO INVO Bioscience
$4.25 /

-0.04 (-0.93%)

Conference/Events
INVO Bioscience management to meet virtually with B. Riley » 10:10
07/19/21
07/19
10:10
07/19/21
10:10
INVO

INVO Bioscience

$3.91 /

-0.03 (-0.76%)

Virtual Meetings to be…

Virtual Meetings to be held on July 26-27 hosted by B. Riley.

ShowHide Related Items >><<
INVO INVO Bioscience
$3.91 /

-0.03 (-0.76%)

INVO INVO Bioscience
$3.91 /

-0.03 (-0.76%)

12/29/20 Roth Capital
Roth Capital starts INVO Bioscience with Buy, $5.75 price target
12/29/20 Roth Capital
INVO Bioscience initiated with a Buy at Roth Capital
12/15/20 Colliers
INVO Bioscience initiated with a Buy at Colliers
INVO INVO Bioscience
$3.91 /

-0.03 (-0.76%)

INVO INVO Bioscience
$3.91 /

-0.03 (-0.76%)

Hot Stocks
INVO Bioscience signs JV agreement with Bloom Fertility » 09:34
06/30/21
06/30
09:34
06/30/21
09:34
INVO

INVO Bioscience

$4.57 /

-0.33 (-6.73%)

INVO Bioscience announced…

INVO Bioscience announced the signing of a joint venture agreement in partnership with reproductive specialist Dr. Sue Ellen Carpenter, M.D. through its wholly-owned subsidiary, INVO Centers, LLC, to open an INVO clinic in Atlanta. The clinic, Bloom Fertility, is scheduled to open in the second half of 2021. Dr. Sue Ellen Carpenter, MD, is Board Certified in Obstetrics and Gynecology. The Company signed clinic partnerships in Birmingham, Alabama and the San Francisco Bay area earlier this year, along with its Mexico partnership in late 2020, which is scheduled to open later this year. These clinics, through the utilization of the INVOcell technology, in addition to the multiple clinic and distribution partnerships throughout the world are bringing advanced fertility care and much needed expanded access to the millions of underserved people. The U.S. INVO clinic agreements are in addition to the distribution agreement the Company previously signed with Ferring Pharmaceuticals, a leader in women's health and signed in early 2019, to broadly commercialize INVOcell across the United States. INVO Bioscience will provide funding for start-up and operating costs and own 40% of the Atlanta Joint Venture.

ShowHide Related Items >><<
INVO INVO Bioscience
$4.57 /

-0.33 (-6.73%)

INVO INVO Bioscience
$4.57 /

-0.33 (-6.73%)

12/29/20 Roth Capital
Roth Capital starts INVO Bioscience with Buy, $5.75 price target
12/29/20 Roth Capital
INVO Bioscience initiated with a Buy at Roth Capital
12/15/20 Colliers
INVO Bioscience initiated with a Buy at Colliers
INVO INVO Bioscience
$4.57 /

-0.33 (-6.73%)

INVO INVO Bioscience
$4.57 /

-0.33 (-6.73%)

Over a quarter ago
Hot Stocks
INVO Bioscience appoints Andrea Goren as CFO » 09:02
06/15/21
06/15
09:02
06/15/21
09:02
INVO

INVO Bioscience

$5.10 /

-0.06 (-1.16%)

INVO Bioscience announced…

INVO Bioscience announced the appointment of Andrea Goren as the Company's CFO. In a career approaching 27 years, Goren has extensive experience in numerous financial functions, including service as a public company CFO, company director, capital raising activities as well as mergers and acquisition experience. Goren has served as managing director and CFO of Phoenix Group, a New York City-based private equity firm specializing in micro-cap and nano-cap public companies. He served as vice president of Shamrock Group, the Roy Disney family private investment firm in London; and was a director at New York City-based Madison Capital Group, a corporate advisory firm focused on U.S. / European Union cross border transactions. Goren holds a Bachelor of Arts degree from Connecticut College in New London, Connecticut, and an MBA from the Columbia Business School in New York City.

ShowHide Related Items >><<
INVO INVO Bioscience
$5.10 /

-0.06 (-1.16%)

INVO INVO Bioscience
$5.10 /

-0.06 (-1.16%)

12/29/20 Roth Capital
Roth Capital starts INVO Bioscience with Buy, $5.75 price target
12/29/20 Roth Capital
INVO Bioscience initiated with a Buy at Roth Capital
12/15/20 Colliers
INVO Bioscience initiated with a Buy at Colliers
INVO INVO Bioscience
$5.10 /

-0.06 (-1.16%)

INVO INVO Bioscience
$5.10 /

-0.06 (-1.16%)

Earnings
INVO Bioscience reports Q1 EPS (25c), consensus (17c) » 16:26
05/17/21
05/17
16:26
05/17/21
16:26
INVO

INVO Bioscience

$4.05 /

+0.05 (+1.25%)

Reports Q1 revenue $685K,…

Reports Q1 revenue $685K, consensus $590K. As of March 31, the company had a cash position of approximately $8.4M, with additional $504,000 in account receivables received subsequent to quarter end.

ShowHide Related Items >><<
INVO INVO Bioscience
$4.05 /

+0.05 (+1.25%)

INVO INVO Bioscience
$4.05 /

+0.05 (+1.25%)

12/29/20 Roth Capital
Roth Capital starts INVO Bioscience with Buy, $5.75 price target
12/29/20 Roth Capital
INVO Bioscience initiated with a Buy at Roth Capital
12/15/20 Colliers
INVO Bioscience initiated with a Buy at Colliers
INVO INVO Bioscience
$4.05 /

+0.05 (+1.25%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.